Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

(2013) Yu Chen et al.   LANCET

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

(2013) Rongbao Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

(2013) P. R. Dormitzer et al.   Science Translational Medicine

Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm

(2012) Michele Tizzoni et al.   BMC Medicine

Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses

(2012) Alaina J Mooney et al.   Future Virology

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

(2012) Fatimah S Dawood et al.   LANCET INFECTIOUS DISEASES

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

(2012) Benjamin Petsch et al.   NATURE BIOTECHNOLOGY

Nonviral delivery of self-amplifying RNA vaccines

(2012) A. J. Geall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Influenza: Options to Improve Pandemic Preparation

(2012) R. Rappuoli et al.   SCIENCE

RNA-based vaccines

(2012) Jeffrey B. Ulmer et al.   VACCINE

New technologies for influenza vaccines

(2012) Philip Dormitzer et al.   Human Vaccines & Immunotherapeutics

The first influenza pandemic of the new millennium

(2011) Gabriele Neumann et al.   Influenza and Other Respiratory Viruses

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

(2011) Julie E Ledgerwood et al.   LANCET INFECTIOUS DISEASES

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

An alternative renewable source of squalene for use in emulsion adjuvants

(2011) Luis A. Brito et al.   VACCINE

Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective

(2010) Atika Abelin et al.   VACCINE

DNA vaccine manufacture: scale and quality

(2009) Ying Cai et al.   Expert Review of Vaccines

Vaccines: Correlates of Vaccine‐Induced Immunity

(2008) Stanley A. Plotkin   CLINICAL INFECTIOUS DISEASES

Plasmid DNA–Based Vaccines Protect Mice and Ferrets against Lethal Challenge with A/Vietnam/1203/04 (H5N1) Influenza Virus

(2008) Peggy A. Lalor et al.   JOURNAL OF INFECTIOUS DISEASES

Nucleic Acid Isothermal Amplification Technologies—A Review

(2008) Pooria Gill et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS